Tag: Brigham and Women’s Hospital

  • Nation & World

    Berries keep your brain sharp

    A new study by Harvard researchers at Brigham and Women’s Hospital (BWH) finds that a high intake of flavonoid-rich berries, such as strawberries and blueberries, over time, can delay memory decline in older women by two and a half years.

    2 minutes
  • Nation & World

    Insight on triple-negative breast cancer

    Scientists from Harvard-affiliated Brigham and Women’s Hospital and Dana-Farber Cancer Institute and their colleagues have found a genetic marker that predicts which aggressive “triple-negative” breast cancers and certain ovarian cancers are likely to respond to platinum-based chemotherapies.

    4 minutes
  • Nation & World

    New subtype of ovarian cancer identified

    Scientists at Dana-Farber Cancer Institute have identified a subtype of ovarian cancer able to build its own blood vessels, suggesting that such tumors might be especially susceptible to “anti-angiogenic” drugs that block blood vessel formation

    5 minutes
  • Nation & World

    Reaping benefits of exercise minus the sweat

    A team led by researchers at Harvard-affiliated Dana-Farber Cancer Institute has isolated a natural hormone from muscle cells that triggers some of the key health benefits of exercise.

    4 minutes
  • Nation & World

    A humanitarian comes home

    Harvard Medical School Instructor Stephanie Kayden’s educational life came full circle this semester, when she taught a humanitarian studies course in Emerson Hall, where, as an undergraduate philosophy concentrator she honed her own reasoning skills years ago.

    3 minutes
  • Nation & World

    HMS’s Louise Ivers honored

    Harvard Medical School (HMS) Assistant Professor Louise Ivers was awarded the Bailey K. Ashford Medal by the American Society of Tropical Medicine and Hygiene.

    2 minutes
  • Nation & World

    A data bank to battle cancer

    Researchers at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute are collaborating on a massive, long-term effort to collect and analyze tumor tissue from 10,000 cancer patients annually. The researchers hope the data will enable them to understand better how tumors behave, while providing opportunities to test new therapies.

    4 minutes
  • Nation & World

    Impact of cutting co-pay on meds

    Researchers from Harvard-affiliated Brigham and Women’s Hospital evaluated whether eliminating co-payments for specific medications following a heart attack would increase adherence and improve outcomes in patients.

    3 minutes
  • Nation & World

    Cancer clues from another species

    Researchers have decoded the genome of an unlikely ally in the fight against cancer and aging, the naked mole rat, to find clues on why it resists the disease and lives 10 times as long as ordinary mice.

    3 minutes
  • Nation & World

    A better view of heart disease

    In clinical settings, simple 2-D displays of human arteries are more effective than traditional 3-D rainbow models, according to Harvard researchers.

    5 minutes
  • Nation & World

    Affordable cancer treatments available

    Report reveals that readily available and affordable cancer prevention, treatment, and pain relief interventions could decrease deaths and improve the lives of millions in developing countries.

    2 minutes
  • Nation & World

    Breathing easier with lung regeneration

    Harvard researchers have cloned stem cells from the airways of the human lung and have shown that these cells can form into the lung’s alveoli air sac tissue. Mouse models suggest that these same stem cells are deployed to regenerate lung tissue during acute infection, such as during influenza.

    3 minutes
  • Nation & World

    Harvard surgeons perform hand transplant

    Fourteen Harvard surgeons, supported by 36 anesthesiologists, radiologists, nurses, and other medical personnel at Harvard-affiliated Brigham and Women’s Hospital, worked for 12 hours to give a new pair of hands to a 65-year-old Revere man who lost both arms below the elbows and both legs below the knees as a result of a septic infection…

    2 minutes
  • Nation & World

    Biomarker for Huntington’s identified

    In a new research paper published in the Proceedings of the National Academy of Sciences Early Edition online, Harvard-affiliated researchers identify a transcriptional biomarker that may assist in the monitoring of Huntington’s disease activity and in the evaluation of new medications.

    3 minutes
  • Nation & World

    On the cusp of new transplant era

    With the advent of new techniques and anti-rejection drugs, organ transplantation stands on the threshold of a new era, where once-radical surgeries such as face transplants will seem routine, says Bohdan Pomahac, the Brigham and Women’s Hospital surgeon and Harvard Medical School professor who led recent face transplant surgeries.

    4 minutes
  • Nation & World

    The battle for medicine’s soul

    Author and surgeon Atul Gawande says effective medicine requires high-quality care and solid research. But it also requires a willingness to adapt.

    4 minutes
  • Nation & World

    A transplant makes history

    In 1954, Harvard surgeons at the Brigham performed the first successful organ transfer, a kidney exchanged between twins, opening a major medical field, and giving life and hope to thousands of patients.

    7 minutes
  • Nation & World

    Kenneth L. Baughman

    Dr. Kenneth L. Baughman died on November 16, 2009, after being struck by an automobile while running during the American Heart Association Annual Scientific Sessions in Orlando, Florida. His tragic death at age 63 threw into relief the enormous impact he had on the Harvard community in his seven years on our faculty, as the…

    4 minutes
  • Nation & World

    Attacking Ebola

    Two Harvard-led research teams report identifying a critical protein that Ebola virus exploits to cause deadly infections. The protein target is an essential element through which the virus enters living cells to cause disease.

    4 minutes
  • Nation & World

    Too much variety

    More choices for Medicare beneficiaries may not always be better, according to Harvard Medical School research.

    3 minutes
  • Nation & World

    Clearer view of Parkinson’s

    A new study finds that a protein key to Parkinson’s disease has likely been mischaracterized. The protein, alpha-synuclein, appears to have a radically different structure in healthy cells than previously thought, challenging existing disease paradigms and suggesting a new therapeutic approach.

    5 minutes
  • Nation & World

    Sleep, oxygen, and dementia

    Harvard research finds that sleep-disordered breathing is associated with a higher risk of cognitive impairment in older women.

    2 minutes
  • Nation & World

    HSPH receives $14.1M grant

    Harvard School of Public Health (HSPH) has been awarded a $14.1 million, four-year grant from the Bill & Melinda Gates Foundation to test the effectiveness of an innovative checklist-based childbirth safety program in reducing deaths and improving outcomes of mothers and infants in 120 hospitals in India.

    3 minutes
  • Nation & World

    Predicting cancer’s spread

    Harvard researchers at Dana-Farber Cancer Institute (DFCI) have identified a number of cancer genes that endow melanoma tumors with the ability to metastasize, making it possible to predict whether the tumors are likely to spread.

    5 minutes
  • Nation & World

    Sackstein granted $17M for research

    Dermatologist Robert Sackstein has been awarded a prestigious $17 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health.

    1 minute
  • Nation & World

    New face for chimp-attack victim

    A Connecticut woman who was badly disfigured when she was mauled by a pet chimpanzee in 2009 received a full face transplant during surgery at Harvard-affiliated Brigham and Women’s Hospital.

    5 minutes
  • Nation & World

    VHA vs. Medicare: And the winner is …

    A Harvard Medical School-led study shows that cancer care provided by the Veterans Health Administration for men 65 years and older is at least as good as, and by some measures better than, Medicare-funded fee-for-service care obtained through the private sector.

    3 minutes
  • Nation & World

    Increasing odds for survival

    A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and is potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Harvard investigators at the Dana-Farber Cancer Institute.

    3 minutes
  • Nation & World

    Accompanying the underserved

    “The road from policy development to implementation is usually long and rocky, one that must be trod with companions,” Paul Farmer, University Professor and co-founder of Partners In Health, told Harvard Kennedy School graduates on May 25.

    3 minutes